...
首页> 外文期刊>Kidney international. >Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis
【24h】

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis

机译:足细胞足突消失作为局灶节段性肾小球硬化的诊断工具

获取原文
           

摘要

Podocyte foot process effacement is characteristic of proteinuric renal diseases. In minimal change nephrotic syndrome (MCNS) foot processes are diffusely effaced whereas the extent of effacement varies in focal segmental glomerulosclerosis (FSGS). Here we measured foot process effacement in FSGS and compared it to that in MCNS and in normal kidneys. A clinical diagnosis was used to differentiate idiopathic FSGS from secondary FSGS. Median foot process width, determined morphometrically by electron microscopy, was 3236nm in 17 patients with idiopathic FSGS, 1098nm in 7 patients with secondary FSGS, and 1725nm in 15 patients with MCNS, as compared to 562nm in 12 control patients. Multivariate analysis showed that foot process width did not correlate with proteinuria or serum albumin levels but was significantly associated as an independent factor with the type of disease. Foot process width over 1500nm differentiated idiopathic from secondary FSGS with high sensitivity and specificity. Our results show that quantitative analysis of foot processes may offer a potential tool to distinguish idiopathic from secondary FSGS.
机译:足细胞足突消失是蛋白尿性肾脏疾病的特征。在最小变化中,肾病综合征(MCNS)的足部散发消失,而局灶节段性肾小球硬化(FSGS)的消失程度却有所不同。在这里,我们测量了FSGS中的足突,并将其与MCNS和正常肾脏中的足突相比较。临床诊断用于区分特发性FSGS和继发性FSGS。通过电子显微镜术形态学测定的足突宽度中位数在17例特发性FSGS患者中为3236nm,在7例继发性FSGS患者中为1098nm,在15例MCNS患者中为1725nm,而在12例对照患者中为562nm。多变量分析表明,足突宽度与蛋白尿或血清白蛋白水平不相关,但与疾病的类型密切相关。 1500nm以上的足突宽度可将特发性与继发性FSGS区别开来,具有很高的灵敏度和特异性。我们的结果表明,足部过程的定量分析可能提供一种潜在的工具来区分特发性和继发性FSGS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号